Arsenal Capital Partners Acquires Accumen to Enhance Healthcare Diagnostic Solutions
VCBeat (WeChat Official Account: vcbeat) has learned that New York-based private equity firm Arsenal Capital Partners (Arsenal) acquired healthcare testing services provider Accumen on January 17 local time. The terms of the acquisition were not disclosed.
It is reported that since its establishment in 2011, Accumen has secured Series A financing from the specialized investment firm Accretive.
Accumen is a leading healthcare testing services provider that delivers end-to-end strategic services to clinical laboratories, outreach programs, patient blood management systems, and imaging services within healthcare institutions, thereby driving their long-term sustainable development. Leveraging innovative, insight-driven proprietary technologies, Accumen provides relevant consulting services and solutions to its health system partners. By collaborating with hospitals and health systems, Accumen has established new performance standards for enhancing the speed, quality, safety, and sustainability of healthcare delivery, as well as improving the patient care experience.
Steve McLean, Senior Partner at Arsenal, stated: “Accumen boasts a first-class management team with invaluable expertise in hospital operations and clinical improvement. Accumen not only meets the market demand for optimization in the healthcare industry but also promotes its broader development.”
Jeff Osborne, CEO of Accumen, stated, “We are proud of the company we have built and are delighted to partner with Arsenal. We chose Arsenal because of its deep healthcare expertise and mature medical technologies. We believe Arsenal can provide the necessary experience and resources to drive the company’s growth.”
BG Porter, Operating Partner at Arsenal and recently appointed Chair of Accumen’s Board of Directors, stated: “Arsenal and its portfolio companies have been committed to enhancing the quality and cost-effectiveness of healthcare providers. We are delighted to collaborate with Jeff Osborn and his team to refine Accumen’s healthcare testing solutions, and we fully support Accumen’s next phase of growth.”
Arsenal was founded in 2000 and is a leading private equity firm focused on investments in two sectors: middle-market specialized industrials and healthcare. Since its inception, Arsenal has raised approximately $3 billion in institutional equity capital and completed more than 100 transactions, including platform investments and follow-on acquisitions. Arsenal collaborates with management teams to build strategically significant companies with leading market positions, high growth potential, and substantial value creation. The firm’s philosophy centers on partnering with talented management teams, providing them with world-class resources and strategic capital, while fostering open and constructive relationships.
Accretive, founded by J. Michael Cline, is a specialized investment firm dedicated to building exceptional companies. Since its inception in 1999, Accretive has generated over $8 billion in value for its customers, leadership teams, and investment partners, and will continue to support the creation and growth of outstanding enterprises.